An experimental mouse model of musk antibody positive myasthenia gravis

An experimental mouse model of musk antibody positive myasthenia gravis

Detalhes bibliográficos
Principais autores:	Viegas, S, Waters, P, Jacobsen, L, Vincent, A
Formato:	Journal article
Publicado em:	2008

Registros relacionados

PATHOGENIC MECHANISMS UNDERLYING MYASTHENIA GRAVIS ASSOCIATED WITH MUSK ANTIBODIES
por: Viegas, S, et al.
Publicado em: (2009)

Myasthenia gravis with MuSK antibodies
por: Farrugia, M, et al.
Publicado em: (2005)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
por: Vincent, A, et al.
Publicado em: (2006)

Facial muscle atrophy in musk antibody positive myasthenia gravis
por: Farrugia, M, et al.
Publicado em: (2006)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
por: Lee, J, et al.
Publicado em: (2006)

Clinical and immunological correlates in myasthenia gravis associated with musk antibodies
por: Viegas, S, et al.
Publicado em: (2008)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
por: Nilesh Wagh, et al.
Publicado em: (2024-09-01)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
por: McConville, J, et al.
Publicado em: (2002)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
por: Chang, T, et al.
Publicado em: (2009)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
por: Diana Epure, et al.
Publicado em: (2016-06-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
por: Yung-Chuan Huang, et al.
Publicado em: (2008-07-01)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
por: McConville, J, et al.
Publicado em: (2004)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
por: J Gordon Millichap
Publicado em: (2006-08-01)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
por: Shiraishi, H, et al.
Publicado em: (2005)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
por: Amber Eker, et al.
Publicado em: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
por: Zunwei Zhang, et al.
Publicado em: (2020-10-01)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
por: Newsom-Davis, J, et al.
Publicado em: (2001)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
por: Bennett, D, et al.
Publicado em: (2006)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
por: Christiane Schneider-Gold, et al.
Publicado em: (2017-10-01)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
por: Farrugia, M, et al.
Publicado em: (2007)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
por: Ting LI, et al.
Publicado em: (2020-01-01)

Potential mechanisms in MuSK-myasthenia gravis
por: Koneczny, I
Publicado em: (2014)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
por: Shalini Bhaskar, et al.
Publicado em: (2022-01-01)

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
por: Niks, E, et al.
Publicado em: (2006)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
por: Yeh, J, et al.
Publicado em: (2004)

Anti-musk positive myasthenia gravis and three semiological cardinal signs
por: André P.C. Matta, et al.
Publicado em: (2017-01-01)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
por: Koneczny, I, et al.
Publicado em: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
por: Koneczny, I, et al.
Publicado em: (2014)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Aigli G. Vakrakou, et al.
Publicado em: (2023-07-01)

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
por: Shan CAO, et al.
Publicado em: (2019-02-01)

Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report
por: Dipesh Chhetri, et al.
Publicado em: (2025-02-01)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
por: Cao, M
Publicado em: (2021)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
por: Lee, J, et al.
Publicado em: (2016)

MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
por: Benveniste, O, et al.
Publicado em: (2005)

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.
por: Phillips, W, et al.
Publicado em: (2015)

Clinical and functional characteristics of seronegative and musk myasthenia gravis
por: Huda, S
Publicado em: (2017)

Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
por: S. Lanfranconi, et al.
Publicado em: (2011-01-01)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
por: Fangyi Shi, et al.
Publicado em: (2024-11-01)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
por: Farrugia, M, et al.
Publicado em: (2006)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
por: Hoch, W, et al.
Publicado em: (2001)